Research fellow

Dr. Daniel Boakye

Curriculum vitae

Scientific & Professional Experience
  • Since 04.2020: Postdoctoral Research Associate at the Leibniz Institute for Prevention Research and Epidemiology (BIPS), Bremen, Germany.
  • 01.2020-03.2020: Postdoctoral Research Associate at the German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 01.2017-12.2019: Research Assistant at the German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 04.2015-08.2015: Clinical Quality Advisor at Marie Stopes International, Accra, Ghana.
  • 01.2014-03.2015: Nursing Officer at Krispat Ear Centre, Takoradi, Ghana.
  • 12.2012-12.2013: Nursing Officer at New Edubiase Government Hospital, New Edubiase, Ghana.

Education
  • 2017-2019: PhD Epidemiology, Heidelberg University, Heidelberg, Germany.
    Dissertation title: "Associations of comorbidities and other indicators of poor health with treatment patterns and prognosis in colorectal cancer patients."
  • 2015-2016: Master of Public Health (MPH), University of Glasgow, Glasgow, UK.
    Thesis title: "Association between cigarette smoking and sleep disturbance among middle-aged adults in the UK."
  • 2008-2012: BSc (Hons.) Nursing, University of Cape Coast, Cape Coast, Ghana.

Research interests

  • Early-onset type II diabetes and cardiovascular diseases.
  • Risk scores and nomograms for predicting incidence and prognosis of major chronic diseases.
  • Prognostic and treatment-related factors of colorectal cancer.
  • Comorbidities, frailty, and oxidative stress biomarkers and their impacts on treatment decisions and prognosis in cancer survivors.
  • Systematic review and meta-analysis on risk and prognostic factors of cancer and early-onset type II diabetes and cardiovascular diseases.

Memberships

Projects

Selected publications

  • Articles with peer-review

  • Boakye D, Nagrani R, Ahrens W, Haug U, Günther K. The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: A systematic review and meta-analysis. Therapeutic Advances in Medical Oncology. 2021;13:1758835920986520.
    https://doi.org/10.1177/1758835920986520
  • Sakyi SA, Ferguson EL, Mantey R, Kwarteng A, Owiredu E-W, Dadzie RE, Amoani B, Opoku S, Oppong Afraine B, Boakye D. Profiling immuno-metabolic mediators of vitamin B12 deficiency among metformin-treated type 2 diabetic patients in Ghana. PLOS ONE. 2021;16(3):e0249325.
    https://doi.org/10.1371/journal.pone.0249325
  • Boakye D, Jansen L, Halama N, Chang-Claude J, Hoffmeister M, Brenner H. Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients. Therapeutic Advances in Medical Oncology. 2021; (Epub 2021 Apr 22).
    https://doi.org/10.1177/17588359211006348
  • Boakye D, Jansen L, Schöttker B, Jansen EHJM, Halama N, Maalmi H, Gao X, Chang-Claude J, Hoffmeister M, Brenner H. The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity. American Journal of Clinical Nutrition. 2021;113(6):1458-1467. (Epub 2021 Mar 19).
    https://doi.org/10.1093/ajcn/nqaa405
  • Jansen L, Boakye D, Alwers E, Carr PR, Reissfelder C, Schneider M, Martens UM, Chang-Claude J, Hoffmeister M, Brenner H. Uptake rates of novel therapies and survival among privately insured versus publicly insured patients with colorectal cancer in Germany. Journal of the National Comprehensive Cancer Network. 2021;19(4):411-420.
    https://doi.org/10.6004/jnccn.2020.7636
  • Scherer S, Jansen L, Boakye D, Hoffmeister M, Brenner H. Changes in health-related outcomes among colorectal cancer patients undergoing inpatient rehabilitation therapy: A systematic review of observational and interventional studies. Acta Oncologica. 2021;60(1):124-134.
    https://doi.org/10.1080/0284186X.2020.1828620
  • Thong MS-Y, Boakye D, Jansen L, Martens UM, Chang-Claude J, Hoffmeister M, Brenner H, Arndt V. Comorbidities rather than older age are strongly associated with higher utilization of healthcare in colorectal cancer survivors. Journal of the National Comprehensive Cancer Network. 2021; (im Druck).
  • Boakye D, Jansen L, Schöttker B, Jansen EH.M, Schneider M, Halama N, Gào X, Chang-Claude J, Hoffmeister M, Brenner H. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients. International Journal of Cancer. 2020;147(9):2373-2386.
    https://doi.org/10.1002/ijc.33018
  • Boakye D, Walter V, Jansen L, Martens UM, Chang-Claude J, Hoffmeister M, Brenner H. Magnitude of the age-advancement effect of comorbidities in colorectal cancer prognosis. Journal of the National Comprehensive Cancer Network. 2020;18(1):59-68.
    https://doi.org/10.6004/jnccn.2019.7346
  • Gào X, Zhang Y, Boakye D, Li X, Chang-Claude J, Hoffmeister M, Brenner H. Whole blood DNA methylation aging markers predict colorectal cancer survival: A prospective cohort study. Clinical Epigenetics. 2020;12:184.
    https://doi.org/10.1186/s13148-020-00977-4
  • Kyei NNA, Boakye D, Gabrysch S. Maternal mycotoxin exposure and adverse pregnancy outcomes: A systematic review. Mycotoxin Research. 2020;36(2):243-255.
    https://doi.org/10.1007/s12550-019-00384-6
  • Boakye D, Jansen L, Schneider M, Chang-Claude J, Hoffmeister M, Brenner H. Personalizing the prediction of colorectal cancer prognosis by incorporating comorbidities and functional status into prognostic nomograms. Cancers. 2019;11(10):1435.
    https://doi.org/10.3390/cancers11101435
  • Boakye D, Walter V, Martens UM, Chang-Claude J, Hoffmeister M, Jansen L, Brenner H. Treatment selection bias for chemotherapy persists in colorectal cancer cohort studies even after comprehensive propensity score analyses. Clinical Epidemiology. 2019;11:821-832.
    https://doi.org/10.2147/CLEP.S215983
  • Walter V, Boakye D, Weberpals J, Jansen L, Haefeli WE, Martens UM, Knebel P, Chang-Claude J, Hoffmeister M, Brenner H. Decreasing use of chemotherapy in older stage III colon cancer patients irrespective of comorbidities. Journal of the National Comprehensive Cancer Network. 2019;17(9):1089-1099.
    https://doi.org/10.6004/jnccn.2019.7287
  • Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in patients with colorectal cancer: A systematic review and meta-analysis. Cancer Treatment Reviews. 2018;64:30-39.
    https://doi.org/10.1016/j.ctrv.2018.02.003
  • Boakye D, Wyse C, Celis-Morales C, Biello SM, Bailey MES, Dare S, Ward J, Gill JMR, Pell JP, Mackay DF. Tobacco exposure and sleep disturbance in 498208 UK Biobank participants. Journal of Public Health. 2018;40(3):517-526.
    https://doi.org/10.1093/pubmed/fdx102
  • Peng L, Weigl K, Boakye D, Brenner H. Risk scores for predicting colorectal neoplasms in the average-risk population: A systematic review and meta-analysis. The American Journal of Gastroenterology. 2018;113(12):1788-1800.
    https://doi.org/10.1038/s41395-018-0209-2
  • Posters at scientific meetings/conferences

  • Huang J, Patel HK, Lucero-Prisno DE, Boakye D, Chandrasekar VT, Lok V, Liu X, Zhang L, Yuan J, Lao X-Q, Tse SLA, Xu W, Zheng Z-J, Wong MCS. Disease burden, risk factors, and recent trends of colorectal cancer: A global analysis of data from 186 countries. International Digestive Disease Forum (IDDF), 22-23 November 2020, online poster. (Abstract published in: Gut. 2020;69(S2):A5)

For further publications please follow this link:

Teaching

  • Gives lectures on Epidemiology to MSc Epidemiology students at the University of Bremen.

The responsibility for the content of this page lies with Daniel Boakye.